Cash Flow Statement

Acquisitions Amortization Amortization Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Depreciation Expense EBIAT Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

AC Immune (ACIU) Shares Issued (2016 - 2025)

AC Immune has reported Shares Issued over the past 10 years, most recently at -$1251.2 for Q4 2025.

Quarterly Shares Issued changed N/A to -$1251.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7893.4 through Dec 2025, changed 0.31% year-over-year, with the annual reading at $7507.0 for FY2025, 6.05% down from the prior year.
Shares Issued was -$1251.2 for Q4 2025 at AC Immune, down from $6250.5 in the prior quarter.
Over five years, Shares Issued peaked at $558518.6 in Q4 2021 and troughed at -$13272.7 in Q1 2021.
The 5-year median for Shares Issued is $3357.3 (2024), against an average of $52238.9.
Year-over-year, Shares Issued soared 8881.88% in 2021 and then crashed 699.09% in 2023.
A 5-year view of Shares Issued shows it stood at $558518.6 in 2021, then crashed by 99.81% to $1035.5 in 2022, then surged by 444.38% to $5636.8 in 2023, then crashed by 79.52% to $1154.2 in 2024, then crashed by 208.4% to -$1251.2 in 2025.
Per Business Quant, the three most recent readings for ACIU's Shares Issued are -$1251.2 (Q4 2025), $6250.5 (Q3 2025), and $8455.2 (Q2 2025).